Special Issue — Highlights of the 2010 Meeting of the Japan Society of Gene Therapy; Editor: Keiya Ozawa

EDITORIAL
KEIYA OZAWA

AAV-based in vivo Gene Therapy: Toward Clinical Achievements

CLINICAL DEVELOPMENT OF AAV VECTORS
BARRIE J. CARTER

A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION
KEI ADACHI and HIROYUKI NAKAI

GENE THERAPY FOR PARKINSON'S DISEASE: STRATEGIES FOR THE LOCAL PRODUCTION OF DOPAMINE
SHIN-ICHI MURAMATSU, SAYAKA ASARI, KEN-ICHI FUJIMOTO, KEIYA OZAWA and IMAHARU NAKANO

Cancer Gene Therapy: Engineered T Cell Breakthrough and Viral Armamentarium

RECENT PROGRESS AND FUTURE DIRECTIONS USING ENGINEERED T CELLS FOR THE TREATMENT OF CANCER
NACHIMUTHU CHINNASAMY and RICHARD A. MORGAN

SMART ADENOVIRUS NANOCOMPLEXES FOR SYSTEMIC DELIVERY
EUNAH KANG and CHAE-OK YUN

CLINICAL DEVELOPMENT OF A THIRD-GENERATION ONCOLYTIC HSV-1 (G47Δ) FOR MALIGNANT GLIOMA
YASUSHI INO and TOMOKI TODO

Multimodal Gene and Cell Therapies

ADVANCES IN MOLECULAR THERAPY RESEARCH ON DYSTROPHIN-DEFICIENT MUSCULAR DYSTROPHY
TAKASHI OKADA and SHIN'ICHI TAKEDA